To ‘Linfinity’ and Beyond – Salonpas to the Rescue for Jeremy Lin
FLORHAM PARK, NJ; April 11, 2012 – With the of loss to Chicago last night, it’s clear that the New York Knicks need the healthy return of “Linsanity” to go deep in the playoffs. Therefore Hisamitsu America, the manufacturers of Salonpas®, www.salonpas.us, the one and only over-the-counter (“OTC”) pain patch that is FDA approved and clinically proven to provide up to 12 hours of relief, is donating a season’s supply of their topical pain treatment products to Jeremy Lin who recently underwent surgery to repair a chronic meniscus tear in his knee and is expected to be off the court for about six weeks.
“Everyone at Hisamitsu America is rooting for Jeremy Lin’s speedy recovery,” says Patrick Carroll, Senior Marketing Director, Hisamitsu America, based in Florham Park, New Jersey. “We believe our topical analgesic treatments will help Jeremy Lin manage his pain and rebound our hopes for the Knicks in the NBA playoffs this season.”
Hisamitsu Pharmaceutical Co. is an advocate of pill-free treatment options for pain. Their website features pain panacea pointers from a roster of holistic pain management experts including: Dave Endres, Physical Therapist, Co-Founder of SPEAR Physical Therapy in New York City; Dr. Ken Kronhaus, M.D., Ph.D. and Host of Good Day Health with Dr. Ken; and Stephanie Smith, Spa Director and Licensed Massage Therapist at the Viana Hotel & Spa. A link to their advice is below:
“Using a transdermal patch or other topical medication, like a spray or foam, provides a welcome alternative for pain sufferers, including those who prefer to avoid the use of oral over-the-counter (OTC) pain relief medication labeled for minor aches and pains,” says Dr. Ken Kronhaus. “Unlike medications from pills, which must travel through the digestive and circulatory system before reaching their target, the transdermal pain patch goes direct to the site of your pain – providing fast relief right where it hurts. With a topical, you can deliver much less medicine to the body because you’re applying it directly at the site of pain.”
# # #
About Hisamitsu America:
Hisamitsu America is the US division of Hisamitsu Pharmaceutical Co., Inc., founded in 1847, which has specialized in transdermal drug delivery system technology since the introduction of its Salonpas line of patches in 1934. The SALONPAS® product line, which gained early acceptance in Asia and now sells in 50 countries, has pioneered the development of transdermal patches to relieve everyday aches and pains. Today, the Salonpas Pain Relief Patches are the first and only FDA-approved OTC pain patch. For more information, visit www.salonpas.us and www.hisamitsu.co.jp/english.
Media Contact: Nancy Tamosaitis, Vorticom, Inc. 212.532.2208; firstname.lastname@example.org